Oncofactor Corp — Form D
Oncofactor Corp of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-03. The offering totals $6.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-03
- Form: D
- Accession: 0000927087-13-000011
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $1.0M
- Remaining: $5.0M
- Investors: 5
- Date of first sale: 2013-08-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202194
Issuer
- Name: Oncofactor Corp
- CIK: 0001520541
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 1616 EASTLAKE AVE E, SUITE 200, SEATTLE, WA, 98102
- Phone: (206) 957-7300
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Lee Babiss | Director | Cambridge, MA |
| Steve Gillis | Director | New York, NY |
| THONG LE | Director | Seattle, WA |
| Janis Naeve | Director | Gaithersburg, MD |
| Chad Waite | Director | SEATTLE, WA |
| Carl Weissman | Director | San Diego, CA |
| David McElligott | Executive Officer | New York, NY |
| LINDSAY RAYLE | Executive Officer | New York, NY |
| Carl Weissman | Executive Officer | San Diego, CA |
| David Schubert | Executive Officer | New York, NY |
Other filings by this issuer (1)
More